Free medication will soon be provided to low-income cancer patients in the UAE.
It comes following a new agreement between the Ministry of Health and Prevention (MoHAP) and pharmaceutical company, AstraZeneca.
The initiative will benefit those battling bladder and lung cancer as well as patients with lymphoma and acute asthma.
Commenting on the agreement, Leon Wang, Executive VP at International AstraZeneca said: "This initiative, which includes new and innovative treatment for some types of cancer and respiratory diseases, would help patients, who are under limited medical insurance."
Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department said that the initiative would help enhance community responsibility values for companies.

UAE bans citizens from travel to Iran, Lebanon and Iraq
UAE charges 13 people, 6 firms in Port Sudan arms trafficking case
H.H. Sheikh Mohammed honours winners of Erth Dubai Awards
UAE, French foreign ministers review regional developments
UAE petrol prices to go up in May
UAE plans nationwide events for International Workers' Day
UAE's supply chain system maintains efficiency: UAE minister
UAE reaffirms support for Gaza peace plan at UN debate
